Swyer, 1984 - Google Patents
Determination of progestational potency: a reviewSwyer, 1984
View PDF- Document ID
- 5476231059843471926
- Author
- Swyer G
- Publication year
- Publication venue
- Journal of the Royal Society of Medicine
External Links
Snippet
The introduction of the 19-norsteroids in the early 1950s provided clinicians with a range of orally-active compounds possessing some, though not all, of the physiological effects of progesterone. Up till that time the only available orally-active progestogen was ethisterone …
- 230000001072 progestational 0 title abstract description 14
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S514/00—Drug, bio-affecting and body treating compositions
- Y10S514/899—Menstrual disorder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S514/00—Drug, bio-affecting and body treating compositions
- Y10S514/841—Contraceptive
- Y10S514/843—Female mammal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/0012—Ovulation-period determination
- A61B2010/0016—Ovulation-period determination based on measurement of electric currents, e.g. conductivity tests
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/0012—Ovulation-period determination
- A61B2010/0019—Ovulation-period determination based on measurement of temperature
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Carruthers et al. | Raised serum copper and caeruloplasmin levels in subjects taking oral contraceptives | |
| Wyshak et al. | Lower prevalence of benign diseases of the breast and benign tumours of the reproductive system among former college athletes compared to non-athletes | |
| Nilsson et al. | Tissue concentrations of levonorgestrel in women using a levonorgestrel‐releasing IUD | |
| Mishell Jr et al. | Estrogenic activity in women receiving an injectable progestogen for contraception | |
| Brown et al. | The effect of norethisterone and its acetate on ovarian and pituitary function during the menstrual cycle | |
| Stevens et al. | The effects of a new oral contraceptive on gonadotropin excretion | |
| GREENBLATT | The progestational activity of 17-α-ethinyl-19-nortestosterone | |
| Pelosi et al. | Galactorrhea-amenorrhea syndrome associated with heroin addiction | |
| Gambrell Jr et al. | Post-pill and pill-related amenorrhea-galactorrhea | |
| Bachman et al. | Excretion of sodium pregnanediol glucuronidate in urine of normal human pregnancy | |
| PERKINS et al. | Practical aspects of insufficiency of the anterior pituitary gland in the adult | |
| Boon et al. | Plasma gonadotropin secretory patterns in patients with functional menstrual disorders and Stein-Leventhal syndrome: response to clomiphene treatment | |
| Swyer | Determination of progestational potency: a review | |
| Flowers | Effects of new low-dosage form of norethynodrel-mestranol: Clinical evaluation and endometrial biopsy study | |
| GREENBLATT et al. | Physiologic effectiveness of oral progesterone | |
| ORR et al. | Luteinizing hormone levels in plasma and urine in women during normal menstrual cycles and in women taking combined contraceptives or chlormadinone acetate | |
| FRANK et al. | Amenorrhea: its causation and treatment | |
| Mishell Jr et al. | Effect of varying dosages of ethynodiol diacetate upon serum luteinizing hormone | |
| SMITH JR et al. | Variations in endocrine gland function in postpartum pituitary necrosis | |
| Elstein et al. | The effect of daily norethisterone (0.35 mg) on cervical mucus and on urinary LH, pregnanediol and oestrogen levels | |
| Jandrain et al. | Effects of ethinyl estradiol combined with desogestrel and cyproterone acetate on glucose tolerance and insulin response to an oral glucose load: A one-year randomized, prospective, comparative trial | |
| Keifer et al. | A clinical evaluation of a monthly injection for conception control | |
| Bell et al. | The effect of the long term administration of oral contraceptives on excretion values for follicle-stimulating hormone and luteinising hormone | |
| Nadler et al. | Hormone levels and anogenital swelling of female chimpanzees as a function of estrogen dosage in a combined oral contraceptive | |
| FRANK et al. | Clinical and laboratory investigations of some of the newer sex hormone preparations |